International Journal of Clinical Research

Objective To focus on exploring the clinical value of Xuanbai Chengqi Decoction in the auxiliary treatment of cough patients with severe pneumonia caused by phlegm-heat congestion in the lungs, and to summarize and analyze its influence on the disease efficacy, the process of cough symptom relief, and the levels of inflammatory factors. Methods Sixty patients clinically diagnosed with severe pneumonia of phlegm-heat congestion lung type in the past two years, with cough as the main symptom, were included. They were randomly divided into the control group and the observation group according to the principle of random allocation, with 30 cases in each group, to ensure balanced and comparable baseline characteristics between the groups. Conventional Western medical treatment (control group) and Xuanbai Chengqi Decoction treatment (observation group) were carried out separately in each group. Targeted comparisons were made in terms of clinical efficacy, relief time of cough symptoms, and levels of inflammatory factors (PCT, IL-6, CRP) after treatment between the two groups. Results The total effective rate of the observation group was higher than that of the control group (P<0.05), and the cough relief time of the observation group was shorter than that of the control group (P<0.05). After treatment, the levels of PCT, IL-6 and CRP in the observation group were lower than those in the control group (P<0.05). Conclusion Xuanbai Chengqi Decoction as an adjunctive treatment for patients with severe pneumonia cough caused by phlegm-heat congestion in the lungs can enhance the therapeutic effect, shorten the time for cough relief, reduce the levels of inflammatory factors, and improve the patient's condition.

Xuanbai Chengqi decoction; Phlegm-heat obstructing lung syndrome; Severe pneumonia; Cough; Inflammatory factors